BioAmber Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013
Product sales
Cost of goods sold excluding depreciation and amortization
Gross loss
Operating expenses
General and administrative
Research and development, net
Sales and marketing
Depreciation of property and equipment and amortization of intangible assets
Write-off of intangible assets (Note 6)
Impairment loss and write-off of property and equipment and of intangible assets (Note 2, 5 and 6)
Foreign exchange loss (gain), net
Operating expenses
Operating loss
Amortization of deferred financing costs and debt discounts
Financial charges (income), net (Note 13)
Financial (income) charges, net (Note 10)
Grant income (Note 9)
Gain on debt extinguishment, net (Note 8)
Equity participation in losses of equity method investment (Note 3)
Gain on re-measurement of Bioamber S.A.S (Note 4)
Other expense (income), net
Loss before income taxes
Income (recovery) taxes (Note 14)
Net loss
Net loss per share attributable to BioAmber Inc. shareholders - basic
Weighted-average number of common shares outstanding - basic
Net loss attributable to:
BioAmber Inc. shareholders
Non-controlling interest

Comments